Aims To study reaction of photoactivated frusemide (F) and F glucuronide (F
gnd metabolite) with human serum albumin in order to find a clue to clarify
a mechanism of phototoxic blisters from high frusemide dosage.
Methods F was exposed to light in the presence of human serum albumin (HSA)
. HSA treated with this method (TR-HSA) was characterized by fluorescence s
pectroscopic experiment, alkali treatment and reversible binding experiment
.
Results Less 4-hydroxyl-N-furfuryl-5-sulphamoylanthranilic acid (4HFSA, a p
hotodegradation product of F) was formed in the presence of HSA than in the
absence of HSA. A new fluorescence spectrum excited at 320 nm was observed
for TR-HSA. Alkali treatment of TR-HSA released 4HFSA. Quenching of the fl
uorescence due to the lone tryptophan near the warfarin-binding site of HSA
was observed in TR-HSA. The reversible binding of F or naproxen to the war
farin-binding site of TR-HSA was less than to that of native HSA. These res
ults indicate the photoactivated F was covalently bound to the warfarin-bin
ding site of HSA. The covalent binding of Fgnd, which is also reversibly bo
und to the wafarin-binding site of HSA, was also induced by exposure to sun
light. Fgnd was more photoactive than F, indicating that F could be activat
ed by glucuronidation to become a more photoactive compound.
Conclusions The reactivity of photoactivated F and Fgnd to HSA and/or to ot
her endogenous compounds may cause the phototoxic blisters that result at h
igh F dosage.